Canada Platelet Rich Plasma (prp) Market Size & Outlook
Canada platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
Canada platelet rich plasma (prp) market highlights
- The Canada platelet rich plasma (prp) market generated a revenue of USD 35.6 million in 2023 and is expected to reach USD 178.1 million by 2030.
- The Canada market is expected to grow at a CAGR of 25.9% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
Platelet rich plasma (prp) market data book summary
| Market revenue in 2023 | USD 35.6 million |
| Market revenue in 2030 | USD 178.1 million |
| Growth rate | 25.9% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, Canada accounted for 5.5% of the global platelet rich plasma (prp) market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. platelet rich plasma (prp) market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 178.1 million by 2030.
Pure prp was the largest segment with a revenue share of 51.69% in 2023. Horizon Databook has segmented the Canada platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
Over the past few years, PRP has been increasingly popular in esthetic and medical fields in Canada. PRP treatments are being promoted locally as safe & efficient medical and cosmetic interventions. However, until July 2020, Health Canada did not clear the status and classification of PRP therapies.
On July 18, 2020, Health Canada confirmed the status of distinction between PRP and stem cells, confirming PRP therapy as an approved procedure. Thus, Health Canada's declaration regarding the use of PRP is expected to expand the market and encourage local entities to enter the market.
Furthermore, the presence of major service providers in the country, such as Canada Diagnostics Centers (CDC), is expected to contribute to the market growth by increasing the local availability of PRP treatments. The majority of the service providers in the country focus on esthetic treatments using PRP systems, thus boosting the penetration of PRP therapies across cosmetics and dermatology marketspace.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada platelet rich plasma (prp) market size, by type, 2018-2030 (US$M)
Canada Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
